GRAIL, LLC (GRAL) revenue breakdown

Healthcare · Diagnostics & Research · Market cap $6.6B

By product, Screening revenue is the largest at 94% of fiscal 2025 revenue, growing 52% a year over 3 years.

Revenue by product

Fiscal years, as GRAIL, LLC reports them in its 10-K filings; fiscal 2025 total $147M.

Products2022202320242025Share
Screening revenue$40M$75M$109M$139M 94%
Development Services$16M$18M$17M$9M 6%
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for GRAL.
Open GRAL in Investingly

Questions

Where does GRAIL, LLC make its money?

In fiscal 2025, by product: Screening revenue $139M, Development Services $9M.

From GRAIL, LLC's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.